Relaxin/RXFP1 signaling in prostate cancer progression

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 379-380

  Feng, Shu ^a   Agoulnik, Irina U ^a   Li, Zhen ^a   Han, Hee Dong ^b   Lopez Berestein, Gabriel ^b   Sood, Anil ^b   Ittmann, Michael M ^a   Agoulnik, Alexander I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Prostate cancer; Relaxin; RXFP1; SiRNA; TRAMP

Indexed keywords

RELAXIN; SMALL INTERFERING RNA;

ANIMAL MODEL; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 64549159375     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03793.x     Document Type: Conference Paper

References (3)

1. Feng, S., I. U. Agoulnik, N. V. Bogatcheva, et al. 2007. Relaxin promotes prostate cancer progression. Clin. Cancer Res. 13: 1695-1702.
2. Hsu, S. Y., K. Nakabayashi, S. Nishi, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
3. Scott, D. J., S. Layfield, Y. Yan, et al. 2006. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. J. Biol. Chem. 281: 34942-34954.